English

GoodRX Jan-Mar 2021 Financial Results

English

Have you heard of GoodRX (ticker symbol: GDRX), a U.S. stock?

It is a company that operates a price comparison app for prescription drugs.

In this article, I will introduce the company’s financial results for the period January to March 2021, which were announced on May 14, 2021.

January to March 2021

EPS is 7¢ vs. 7¢ forecast.

Net sales: $160 million vs. forecast of $160 million.

Sales growth was +20.2% YoY.

Net income was $1.7 million.

Monthly customers were 5.7 million, up 17% from the same period last year. This compares to 4.9 million in the same period last year.

Subscription plan customers increased 96% year-over-year to 931,000. In the same period last year, the number was 475,000.

Operating cash flow was $45.5 million. Cash flow from operations was $45.5 million compared to $45.6 million in the same period last year.

スポンサーリンク
ABOUT ME
HATOMAME

こんにちは、ハトマメです。
(Hello, my name is HATOMAME.)
(你好,我的名字是HATOMAME。)
(Hola, mi nombre es HATOMAME.)

ハトマメブログ(HATOMAME BLOG)
タイトルとURLをコピーしました